Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Disc Medicine Inc
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval
Today 7:50 EST
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
November 01, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week
October 25, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer
October 23, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
October 11, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer
September 19, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine to Participate in Upcoming Investor Conferences
August 30, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Announces Underwritten Offering of Common Stock
June 14, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
June 14, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
May 14, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
May 13, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
April 01, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 21, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
March 06, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
February 26, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
February 20, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera
February 09, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer
February 07, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board
December 20, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting
December 11, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual Meeting
December 11, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with Bitopertin
November 14, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business Update
November 09, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine to Participate in Upcoming Investor Conferences
November 08, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program Updates
November 02, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Disc Medicine Announces Planned Departure of Chief Financial Officer Joanne Bryce
October 23, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.